Skip to main content
Premium Trial:

Request an Annual Quote

CovalX Inks Deal with ASPEC to Sell Protein Analysis Tech in Greater China Market

Premium

CovalX and ASPEC Technologies said this week that they have signed a distribution agreement to sell CovalX's mass spec-based protein interaction and protein characterization tools into the greater China market.

The agreement combines CovalX's products with ASPEC's commercial partnerships and infrastructure in this region, providing ASPEC customers with exclusive access to CovalX's protein analysis tools, the companies said.

CovalX's MALDI mass spec-based HM3 platform allows for protein-protein analyses including stoichiometry, biotherapeutic aggregation, epitope mapping, and immunocomplex characterization.

The deal covers ASPEC customers in mainland China, Hong Kong, Macau and Taiwan. Financial and other terms were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.